Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Neoplasm With Metastasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00057889
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Metastatic Renal Cell Cancer

Who this might be right for
Kidney Cancer
National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Study completedNCT00563147
What this trial is testing

A Phase 1b, Open-Label, Dose-Finding Study to Evaluate the Safety of Tivozanib (AV-951) in Combination With Temsirolimus in Subjects With Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
AVEO Pharmaceuticals, Inc. 28
Not applicableEnded earlyNCT04147143
What this trial is testing

CaboCHECK - Cabozantinib in Adult Patients With Advanced Renal Cell Carcinoma Following Prior Systemic Check Point Inhibition Therapy: a Retrospective, Non-interventional Study

Who this might be right for
Advanced Renal Cell Carcinoma (All Subtypes)Metastatic Renal Cell Carcinoma (All Subtypes)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 56
Testing effectiveness (Phase 2)Study completedNCT00835978
What this trial is testing

Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer

Who this might be right for
Carcinoma, Renal Cell
Pfizer 213
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07470840
What this trial is testing

SBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell Carcinoma

Who this might be right for
Locally Advanced or Metastatic Renal Cell Carcinoma
Fujian Cancer Hospital 27
Early research (Phase 1)Active Not RecruitingNCT06049576
What this trial is testing

Nivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell CarcinomaSarcomatoid Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+1 more
City of Hope Medical Center 31
Very early researchNot Yet RecruitingNCT07671417
What this trial is testing

Imaging Study in Metastatic Clear Cell RCC.

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
RayzeBio, Inc. 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT03634540
What this trial is testing

A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)

Who this might be right for
Renal Cell Carcinoma (RCC)Clear Cell Renal Cell Carcinoma (ccRCC)Kidney Cancer+6 more
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 118
Early research (Phase 1)Study completedNCT01625936
What this trial is testing

CRLX101 Plus Bevacizumab in Advanced RCC

Who this might be right for
Renal Cell Carcinoma
Abramson Cancer Center at Penn Medicine 22
Testing effectiveness (Phase 2)Ended earlyNCT01793636
What this trial is testing

A Study Comparing AZD2014 vs Everolimus in Patients With Metastatic Renal Cancer

Who this might be right for
Metastatic Clear Cell Renal Carcinoma
Queen Mary University of London 49
Testing effectiveness (Phase 2)Study completedNCT00021021
What this trial is testing

RPI.4610 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Ribozyome
Testing effectiveness (Phase 2)Study completedNCT01328574
What this trial is testing

TRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma

Who this might be right for
Urothelial CarcinomaUreteral NeoplasmsUreter Cancer+2 more
National Cancer Institute (NCI) 13
Early research (Phase 1)Study completedNCT01525017
What this trial is testing

A Clinical Study to Evaluate Safety and Immunologic Response of COMBIG-DC, in Patients With Metastatic Kidney Cancer

Who this might be right for
Metastatic Renal Cell Carcinoma
Mendus 12
Testing effectiveness (Phase 2)Ended earlyNCT00323791
What this trial is testing

Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer

Who this might be right for
Kidney Cancer
University of Medicine and Dentistry of New Jersey 100
Not applicableStudy completedNCT01586104
What this trial is testing

Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases

Who this might be right for
Adult RhabdomyosarcomaLung MetastasesMetastatic Ewing Sarcoma+9 more
Ann & Robert H Lurie Children's Hospital of Chicago 20
Testing effectiveness (Phase 2)Study completedNCT00142415
What this trial is testing

Phase I/II Dose-escalation Study of Lutetium-177-labeled cG250 in Patients With Advanced Renal Cancer

Who this might be right for
Metastatic Renal Cell Carcinoma
Ludwig Institute for Cancer Research 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT03682289
What this trial is testing

Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

Who this might be right for
Clear Cell Renal Cell CarcinomaLocally Advanced Pancreatic CancerLocally Advanced Malignant Solid Neoplasm+10 more
Rahul Aggarwal 83
Not applicableLooking for participantsNCT07753343
What this trial is testing

Identification and Description of Patients With High-risk Non Metastatic RCC

Who this might be right for
Renal Cell Carcinoma
University Hospital, Bordeaux 6,109
Testing effectiveness (Phase 2)UnknownNCT04644432
What this trial is testing

Individualized Treatment Strategy for Patients With Metastatic Non-clear Cell Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell CarcinomaKidney NeoplasmUrologic Neoplasms+1 more
Herlev and Gentofte Hospital 30
Not applicableStudy completedNCT05650164
What this trial is testing

Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART2)

Who this might be right for
Renal Cell Carcinoma
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 171
Next Page